Motus GI Holdings Incの収益はセグメントまたは地域別にどのように分けられていますか?
Motus GI Holdings Incは収益を上げていますか?
Motus GI Holdings Incに負債はありますか?
Motus GI Holdings Incの発行済株式数は何株ですか?
主要データ
前終値
$0.0002
始値
$0.0002
当日レンジ
$0.0002 - $0.0002
52週レンジ
$0 - $0.1
取引高
1
平均取引高
1.0K
1株当たり利益(TTM)
-12.69
配当利回り
--
時価総額
$1.2K
MOTSとは何ですか?
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 15 full-time employees. The company went IPO on 2018-02-14. The company has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.